preferred_name: Hereditary breast cancer-related disorders genomic sequence analysis panel utilizing a combination of next-generation sequencing (NGS), Sanger, multiplex ligation-dependent probe amplification (MLPA), and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (17 genes sequencing for detection of deletion and duplication)